인간성장호르몬 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 9.8%의 성장률로 76억 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 맞춤형 의료의 출현, 세계 헬스케어 지출 증가, 재조합 DNA 기술 채택 확대, 호르몬 대체요법에 대한 수요 증가, 내분비 질환의 유병률 증가 등에 기인할 것으로 보입니다. 예측 기간의 주요 동향으로는 신흥국 시장에서의 유통망 확대, 의약품 개발에 인공지능의 통합, 지속가능한 제조 공정의 중요성, 장기 지속형 제제 개발, 유효성 향상을 위한 병용요법 활용 등이 있습니다.
치료 절차에 대한 인식이 높아짐에 따라 향후 인간성장호르몬 시장의 성장을 견인할 것으로 예상됩니다. 치료에는 건강 상태 및 질병의 완화, 관리 및 치유를 목적으로 하는 의료 개입이 포함됩니다. 이러한 인식의 증가는 의료 기술의 발전, 디지털 미디어를 통한 정보 접근성 강화, 건강 및 웰빙에 대한 사람들의 관심 증가에 의해 촉진되고 있습니다. 인간성장호르몬(HGH) 치료는 미디어의 큰 관심과 대중의 관심을 끌며 최신 의료 개입의 이점과 잠재적 응용을 강조하여 치료 절차에 대한 전반적인 인식을 높이고 있습니다. 예를 들어, 약물 남용 및 정신보건관리국(SAMHSA)의 2022년 전국 약물사용 및 건강조사(NSDUH) 보고서에 따르면, 2021년 12-17세 청소년 중 지난 1년간 주요우울증(MDE)을 경험한 500만 명의 청소년 중 40.6%가 우울증 치료를 받고 있는 것으로 나타났습니다. 우울증 치료를 받고 있으며, 2022년에는 지난 1년간 MDE를 경험한 480만 명의 청소년 중 56.8%가 정신건강 치료를 받고 있는 것으로 나타났습니다. 이에 따라 치료 절차에 대한 인식이 높아지면서 인간성장호르몬 시장의 성장을 견인하고 있습니다.
인간성장호르몬 시장의 주요 기업들은 의약품을 보강하고 우수한 치료 솔루션을 제공하기 위해 의약품 개발 및 승인에 대한 노력을 강화하고 있습니다. 의약품 개발에는 신약이 시장에 출시되기 전에 안전성, 유효성 및 품질을 보장하기 위해 여러 단계를 포함하는 포괄적이고 면밀한 프로세스가 포함됩니다. 예를 들어, 2023년 6월, 미국 바이오제약회사 화이자와 미국 바이오제약 및 진단약 회사인 OPKO Health Inc.는 NGENLA(somatrogon-ghla)가 미국 식품의약국(FDA)의 승인을 받았다고 발표하였습니다. 이 치료법은 매일 주사하는 것보다 편리한 투여 방법을 제공하여 환자의 복약 순응도를 높입니다. FDA의 승인은 NGENLA가 1일 1회 소마트로핀 대비 비열등하고 안전성 프로파일이 소마트로핀과 동등하다는 것을 입증한 3상 임상연구를 통해 뒷받침되었습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신종 코로나바이러스 감염증, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 인간성장호르몬 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업 분석
- 세계의 인간성장호르몬 시장 : 성장률 분석
- 세계의 인간성장호르몬 시장 실적 : 규모와 성장, 2019-2024
- 세계의 인간성장호르몬 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 인간성장호르몬 전체 시장(TAM)
제6장 시장 세분화
- 세계의 인간성장호르몬 시장 : 제품별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 액체
- 분
- 세계의 인간성장호르몬 시장 : 브랜드별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- Norditropin
- Genotropin
- Humatrope
- Saizen
- Omnitrope
- Skytrofa
- 기타 브랜드
- 세계의 인간성장호르몬 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 경구
- 정맥내
- 근육내
- 피하
- 세계의 인간성장호르몬 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 병원 약국
- 소매 약국
- 온라인 약국
- 전문 약국
- 세계의 인간성장호르몬 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 성장호르몬(GH) 결핍증
- 성인 성장호르몬(GH) 결핍증
- 소아 성장호르몬(GH) 결핍증
- 터너증후군
- 특발성 저신장
- 프라더 윌리-증후군
- 임신주수에 대해서 작다
- 기타 용도
- 세계의 인간성장호르몬 시장, 액체 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 프리필드 시린지
- 액체 성장호르몬 바이알
- 세계의 인간성장호르몬 시장, 분말 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 재구성 가능한 분말
- 동결건조 분말
제7장 지역별·국가별 분석
- 세계의 인간성장호르몬 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 인간성장호르몬 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 인간성장호르몬 시장 : 경쟁 구도
- 인간성장호르몬 시장 : 기업 개요
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
- Novo Nordisk A/S
- Merck KGaA
- Teva Pharmaceutical Industries Ltd.
- Sandoz International GmbH
- Ipsen Pharma
- Ferring Holding SA
- Endo International
- Zydus Lifesciences Limited
- Opko Health
- LG Life Sciences
- EMD Serono Inc.
- Wockhardt Ltd.
- JCR Pharmaceuticals Co. Ltd.
- Genentech Inc.
- Shanghai United Imaging Healthcare Co. Ltd.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 인간성장호르몬 시장 2029 : 새로운 기회를 제공하는 국가
- 인간성장호르몬 시장 2029 : 새로운 기회를 제공하는 부문
- 인간성장호르몬 시장 2029 : 성장 전략
제36장 부록
ksm
Human growth hormone (HGH) is a peptide hormone originating from the pituitary gland, playing a vital role in encouraging growth, cell replication, and tissue renewal across the human body. It finds application in medical interventions targeting growth hormone deficiency, promoting muscle growth, and addressing age-related issues such as muscle atrophy and decreased bone density.
The primary forms of human growth hormone are liquid and powder. Liquid human growth hormone products are typically presented as a solution or suspension, readily available for immediate consumption or injection. These include various brands such as Norditropin, Genotropin, Humatrope, Saizen, Omnitrope, Skytrofa, among others, administered via different routes such as oral, intravenous, intramuscular, or subcutaneous. These products are distributed through diverse channels such as hospital pharmacies, retail pharmacies, online pharmacies, and specialty pharmacies, catering to a range of applications such as growth hormone (GH) deficiency, adult GH deficiency, pediatric GH deficiency, Turner syndrome, idiopathic short stature, Prader-Willi syndrome, small for gestational age, and others.
The human growth hormone market research report is one of a series of new reports from The Business Research Company that provides human Growth hormone market statistics, including human growth hormone industry global market size, regional shares, competitors with a human growth hormone market share, detailed human growth hormone market segments, market trends, and opportunities, and any further data you may need to thrive in the human growth hormone industry. This human growth hormone market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The human growth hormone market size has grown rapidly in recent years. It will grow from $4.75 billion in 2024 to $5.23 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to increasing prevalence of growth disorders, rising awareness about hormone therapies, expanding applications in sports medicine, growing geriatric population, improving healthcare infrastructure.
The human growth hormone market size is expected to see strong growth in the next few years. It will grow to $7.6 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to emergence of personalized medicine, rising healthcare expenditure globally, increasing adoption of recombinant DNA technology, growing demand for hormone replacement therapies, rising prevalence of endocrine disorders. Major trends in the forecast period include expansion of distribution networks in emerging markets, integration of artificial intelligence in drug development, emphasis on sustainable manufacturing processes, development of long-acting formulations, utilization of combination therapies for enhanced efficacy.
The increasing awareness of treatment procedures is anticipated to drive the expansion of the human growth hormone market in the future. Treatment procedures encompass medical interventions aimed at alleviating, managing, or curing health conditions or diseases. This heightened awareness is fueled by advancements in medical technology, enhanced access to information via digital media, and a growing public interest in health and wellness. Human growth hormone (HGH) treatments have attracted significant media attention and public interest, underscoring the benefits and potential applications of modern medical interventions, thereby boosting overall awareness of treatment procedures. For example, according to the 2022 National Survey on Drug Use and Health (NSDUH) report by the Substance Abuse and Mental Health Services Administration (SAMHSA), among adolescents aged 12 to 17, in 2021, 40.6% of the 5.0 million adolescents with a past year Major Depressive Episode (MDE) received treatment for depression, while in 2022, 56.8% of the 4.8 million adolescents with a past year MDE received mental health treatment. Consequently, the heightened awareness of treatment procedures is propelling the growth of the human growth hormone market.
Leading companies in the human growth hormone market are intensifying their efforts in drug development and approvals to enhance their medication offerings and provide superior treatment solutions. Drug development entails a comprehensive and meticulous process involving multiple stages to ensure the safety, efficacy, and quality of a new drug before it is introduced to the market. For example, in June 2023, Pfizer Inc., a US-based biopharmaceutical company, and OPKO Health Inc., a US-based biopharmaceutical and diagnostics company, announced the approval of NGENLA (somatrogon-ghla) by the Food and Drug Administration (FDA). This treatment offers a more convenient dosing regimen and enhances patient adherence compared to daily injections. It provides children with growth hormone deficiency the option to reduce injection frequency from daily to once a week. The FDA approval was supported by a Phase 3 study demonstrating NGENLA's non-inferiority to once-daily somatropin, with a safety profile comparable to somatropin.
The increasing healthcare expenditure is expected to drive the growth of the human growth hormone (HGH) market in the coming years. Healthcare expenditure refers to the total spending on health services, products, and interventions aimed at improving and maintaining health. HGH therapy provides a unique approach to reducing healthcare costs by addressing underlying health issues that contribute to long-term expenses, enhancing recovery and quality of life, and potentially preventing the onset of expensive chronic conditions. For instance, in May 2023, a report from the Office for National Statistics, a UK-based government agency, indicated that healthcare spending in the UK grew by 5.6% between 2022 and 2023, compared to just 0.9% in 2022. The total healthcare expenditure in the UK was approximately $317.63 billion (£292 billion) in 2023. As a result, the rise in healthcare spending is expected to drive the human growth hormone market forward.
Major companies operating in the human growth hormone market are Pfizer Inc., Roche Holding AG, Novartis AG, Thermo Fisher Scientific Inc., Eli Lilly and Company, Novo Nordisk A/S, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Ipsen Pharma, Ferring Holding SA, Endo International, Zydus Lifesciences Limited, Opko Health, LG Life Sciences, EMD Serono Inc., Wockhardt Ltd., JCR Pharmaceuticals Co. Ltd., Genentech Inc., Shanghai United Imaging Healthcare Co. Ltd., SOFAR S.p.A., United Laboratories, Ascendis Pharma, Uni-Pharma S.A., Versartis Inc., Reliance Life Sciences, Anhui Anke Biotechnology (Group) Co. Ltd., Rani Therapeutics
North America was the largest region in the human growth hormone market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human growth hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the human growth hormone market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The human growth hormone market consists of sales of combination therapies, sustained-release formulations, long-acting formulations, biosimilar versions, pediatric-specific formulations, and personalized dosing regimens. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Human Growth Hormone Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on human growth hormone market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for human growth hormone ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The human growth hormone market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product: Liquid; Powder
- 2) By Brand: Norditropin; Genotropin; Humatrope; Saizen; Omnitrope; Skytrofa; Others Brands
- 3) By Route Of Administration: Oral; Intravenous; Intramuscular; Subcutaneous
- 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacy; Specialty Pharmacy
- 5) By Application: Growth Hormone (GH) Deficiency; Adult Growth Hormone (GH) Deficiency; Pediatric Growth Hormone (GH) Deficiency; Turner Syndrome; Idiopathic Short Stature; Prader-Willi Syndrome; Small For Gestational Age; Other Applications
- Subsegments:
- 1) By Liquid: Pre-Filled Liquid Syringes; Vials Of Liquid Growth Hormone
- 2) By Powder: Reconstitutable Powder; Freeze-Dried Powder
- Companies Mentioned: Pfizer Inc.; Roche Holding AG; Novartis AG; Thermo Fisher Scientific Inc.; Eli Lilly and Company
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Human Growth Hormone Market Characteristics
3. Human Growth Hormone Market Trends And Strategies
4. Human Growth Hormone Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Human Growth Hormone Growth Analysis And Strategic Analysis Framework
- 5.1. Global Human Growth Hormone PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Human Growth Hormone Market Growth Rate Analysis
- 5.4. Global Human Growth Hormone Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Human Growth Hormone Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Human Growth Hormone Total Addressable Market (TAM)
6. Human Growth Hormone Market Segmentation
- 6.1. Global Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Liquid
- Powder
- 6.2. Global Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Norditropin
- Genotropin
- Humatrope
- Saizen
- Omnitrope
- Skytrofa
- Others Brands
- 6.3. Global Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Intravenous
- Intramuscular
- Subcutaneous
- 6.4. Global Human Growth Hormone Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacy
- Specialty Pharmacy
- 6.5. Global Human Growth Hormone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Growth Hormone (GH) Deficiency
- Adult Growth Hormone (GH) Deficiency
- Pediatric Growth Hormone (GH) Deficiency
- Turner Syndrome
- Idiopathic Short Stature
- Prader-Willi Syndrome
- Small For Gestational Age
- Other Applications
- 6.6. Global Human Growth Hormone Market, Sub-Segmentation Of Liquid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pre-Filled Liquid Syringes
- Vials Of Liquid Growth Hormone
- 6.7. Global Human Growth Hormone Market, Sub-Segmentation Of Powder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Reconstitutable Powder
- Freeze-Dried Powder
7. Human Growth Hormone Market Regional And Country Analysis
- 7.1. Global Human Growth Hormone Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Human Growth Hormone Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Human Growth Hormone Market
- 8.1. Asia-Pacific Human Growth Hormone Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Human Growth Hormone Market
- 9.1. China Human Growth Hormone Market Overview
- 9.2. China Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Human Growth Hormone Market
- 10.1. India Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Human Growth Hormone Market
- 11.1. Japan Human Growth Hormone Market Overview
- 11.2. Japan Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Human Growth Hormone Market
- 12.1. Australia Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Human Growth Hormone Market
- 13.1. Indonesia Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Human Growth Hormone Market
- 14.1. South Korea Human Growth Hormone Market Overview
- 14.2. South Korea Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Human Growth Hormone Market
- 15.1. Western Europe Human Growth Hormone Market Overview
- 15.2. Western Europe Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Human Growth Hormone Market
- 16.1. UK Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Human Growth Hormone Market
- 17.1. Germany Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Human Growth Hormone Market
- 18.1. France Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Human Growth Hormone Market
- 19.1. Italy Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Human Growth Hormone Market
- 20.1. Spain Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Human Growth Hormone Market
- 21.1. Eastern Europe Human Growth Hormone Market Overview
- 21.2. Eastern Europe Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Human Growth Hormone Market
- 22.1. Russia Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Human Growth Hormone Market
- 23.1. North America Human Growth Hormone Market Overview
- 23.2. North America Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Human Growth Hormone Market
- 24.1. USA Human Growth Hormone Market Overview
- 24.2. USA Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Human Growth Hormone Market
- 25.1. Canada Human Growth Hormone Market Overview
- 25.2. Canada Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Human Growth Hormone Market
- 26.1. South America Human Growth Hormone Market Overview
- 26.2. South America Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Human Growth Hormone Market
- 27.1. Brazil Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Human Growth Hormone Market
- 28.1. Middle East Human Growth Hormone Market Overview
- 28.2. Middle East Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Human Growth Hormone Market
- 29.1. Africa Human Growth Hormone Market Overview
- 29.2. Africa Human Growth Hormone Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Human Growth Hormone Market, Segmentation By Brand, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Human Growth Hormone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Human Growth Hormone Market Competitive Landscape And Company Profiles
- 30.1. Human Growth Hormone Market Competitive Landscape
- 30.2. Human Growth Hormone Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
31. Human Growth Hormone Market Other Major And Innovative Companies
- 31.1. Novo Nordisk A/S
- 31.2. Merck KGaA
- 31.3. Teva Pharmaceutical Industries Ltd.
- 31.4. Sandoz International GmbH
- 31.5. Ipsen Pharma
- 31.6. Ferring Holding SA
- 31.7. Endo International
- 31.8. Zydus Lifesciences Limited
- 31.9. Opko Health
- 31.10. LG Life Sciences
- 31.11. EMD Serono Inc.
- 31.12. Wockhardt Ltd.
- 31.13. JCR Pharmaceuticals Co. Ltd.
- 31.14. Genentech Inc.
- 31.15. Shanghai United Imaging Healthcare Co. Ltd.
32. Global Human Growth Hormone Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Human Growth Hormone Market
34. Recent Developments In The Human Growth Hormone Market
35. Human Growth Hormone Market High Potential Countries, Segments and Strategies
- 35.1 Human Growth Hormone Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Human Growth Hormone Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Human Growth Hormone Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
